Prediction Case File
YouTubeTracking Live

BDMD Stock Price Prediction: What's Next for Baird Medical?

1 extracted signal · 0 resolved · 1 still active

Stocks By Shah Faisal Shah profile imageStocks By Shah Faisal ShahIndependent analyst profile
Source published
09 Nov 2026, 21:15 UTC
Recorded by Tahlil Plus
09 Nov 2026, 23:45 UTC
Video preview for BDMD Stock Price Prediction: What's Next for Baird Medical?
Source overview

AI-generated source summary

Technical analysis of BDMD on the 4-hour chart reveals a strong prevailing downtrend with sellers firmly in control. The primary resistance level is established at 25 cents. Two potential scenarios are monitored: a continuation of the bearish trend targeting 3 cents if resistance holds, or a bullish reversal scenario targeting 49 cents if the 25-cent resistance is broken and successfully retested as support.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Source processing completed

    Source analysis and structured extraction completed.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

Stocks By Shah Faisal Shah

Platform-wide history, separate from this source evaluation.

Reliability
57.1
Tracked signals
122
Historical success
47.5%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail